Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS)

BACKGROUND: This study evaluated the efficacy and safety of baricitinib (Janus kinase-1/2 inhibitor), in adult and pediatric Japanese patients with Nakajo-Nishimura syndrome/chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (NNS/CANDLE), stimulator of interferon ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanazawa, Nobuo, Ishii, Taeko, Takita, Yasushi, Nishikawa, Atsushi, Nishikomori, Ryuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122451/
https://www.ncbi.nlm.nih.gov/pubmed/37087470
http://dx.doi.org/10.1186/s12969-023-00817-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122451/
https://www.ncbi.nlm.nih.gov/pubmed/37087470
http://dx.doi.org/10.1186/s12969-023-00817-8

Ejemplares similares